Patents by Inventor Jan J. Scicinski

Jan J. Scicinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL DOSAGE FORMS
    Publication number: 20200000791
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: May 7, 2019
    Publication date: January 2, 2020
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Oral pharmaceutical dosage forms
    Patent number: 10328068
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: June 25, 2019
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • ORAL PHARMACEUTICAL DOSAGE FORMS
    Publication number: 20180214435
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: December 22, 2017
    Publication date: August 2, 2018
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Oral pharmaceutical dosage forms
    Patent number: 9884056
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: February 6, 2018
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Oral Pharmaceutical Dosage Forms
    Publication number: 20170252330
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: February 16, 2017
    Publication date: September 7, 2017
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Oral pharmaceutical dosage forms
    Patent number: 9616055
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: April 11, 2017
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Oral Pharmaceutical Dosage Forms
    Publication number: 20160058746
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: July 2, 2015
    Publication date: March 3, 2016
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Oral Pharmaceutical Dosage Forms
    Publication number: 20140011842
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: June 21, 2013
    Publication date: January 9, 2014
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Oral pharmaceutical dosage forms
    Publication number: 20100260844
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: November 3, 2009
    Publication date: October 14, 2010
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • INDOLE, BENZIMIDAZOLE, AND BENZOLACTAM BORONIC ACID COMPOUNDS, ANALOGS THEREOF AND METHODS OF USE THEREOF
    Publication number: 20090264384
    Abstract: Benzimidazole, indole and benzolactam boronic acid compounds, analogs thereof, and pharmaceutical formulations are described, along with methods of use thereof for inhibiting inflammatory cytokines such as tumor necrosis factor alpha (TNF-?) in a subject in need thereof.
    Type: Application
    Filed: November 10, 2008
    Publication date: October 22, 2009
    Applicant: Nuada, Inc.
    Inventors: John R. Didsbury, Tatyana Dyakonov, Simon N. Haydar, Michael L. Jones, Francine F. Li, Christopher J. Markworth, Jessy Matthew, Frank J. Schoenen, Jan J. Scicinski, David Middlemiss, James F. Burns, Leonard A. Cabana, Glenn C. Collupy, David N. Vanvliet
  • Compounds and Methods of Use Thereof
    Publication number: 20080319044
    Abstract: Indole boronic acid compounds, and analogs thereof, and pharmaceutical formulations are described, along with methods of use thereof for inhibiting inflammatory cytokines such as tumor necrosis factor alpha (TNF-?) in a subject in need thereof.
    Type: Application
    Filed: October 27, 2005
    Publication date: December 25, 2008
    Applicant: NUADA, LLC
    Inventors: John R. Didsbury, Tatyana A. Dyakonov, Simon N. Haydar, Michael L. Jones, Francine F. Li, Christopher J. Markworth, Jessymol Mathew, Frank J. Schoenen, Jan J. Scicinski, David Middlemiss